{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:58:22Z","timestamp":1788587902765,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11596-015-1501-7","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T04:11:40Z","timestamp":1445487100000},"page":"747-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Modified titration intratympanic gentamicin injection for unilateral intractable M\u00e9ni\u00e8re\u2019s disease"],"prefix":"10.1007","volume":"35","author":[{"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-ming","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-jia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"issue":"9636","key":"1501_CR1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(08)61161-7","volume":"372","author":"H Sajjadi","year":"2008","unstructured":"Sajjadi H, Paparella MM, Meniere\u2019s disease. Lancet, 2008,372(9636):406\u2013414","journal-title":"Lancet"},{"issue":"3","key":"1501_CR2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00005537-200303000-00013","volume":"113","author":"N Perez","year":"2003","unstructured":"Perez N, Martin E, Garcia-Tapia R. Intratympanic gentamicin for intractable Meniere\u2019s disease. Laryngoscope, 2003,113(3):456\u2013464","journal-title":"Laryngoscope"},{"issue":"5","key":"1501_CR3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00129492-200309000-00018","volume":"24","author":"E Martin","year":"2003","unstructured":"Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Meniere\u2019s Disease. Otol Neurotol, 2003,24(5):800\u2013806","journal-title":"Otol Neurotol"},{"key":"1501_CR4","first-page":"293","volume":"52","author":"E ffixJr Fowler","year":"1948","unstructured":"Fowler EP ffixJr. Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol, 1948,52:293\u2013301","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"1501_CR5","first-page":"1","volume":"132","author":"HF Schuknecht","year":"1957","unstructured":"Schuknecht HF. Ablation therapy in the management of Meniere\u2019s disease. Acta Otolaryngol Suppl, 1957,132: 1\u201342","journal-title":"Acta Otolaryngol Suppl"},{"issue":"1","key":"1501_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005537-200401000-00018","volume":"114","author":"G Lange","year":"2004","unstructured":"Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere\u2019s disease. Laryngoscope, 2004,114(1):102\u2013105","journal-title":"Laryngoscope"},{"issue":"2","key":"1501_CR7","first-page":"209","volume":"20","author":"LB Minor","year":"1999","unstructured":"Minor LB. Intratympanic gentamicin for control of vertigo in Meniere\u2019s disease: vestibular signs that specify completion of therapy. Am J Otol, 1999,20(2):209\u2013219","journal-title":"Am J Otol"},{"issue":"1","key":"1501_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00019052-200402000-00004","volume":"17","author":"LB Minor","year":"2004","unstructured":"Minor LB, Schessel DA, Carey JP. Meniere\u2019s disease. Curr Opin Neurol, 2004,17(1):9\u201316","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"1501_CR9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/MAO.0b013e31815aea05","volume":"28","author":"D Bodmer","year":"2007","unstructured":"Bodmer D, Morong S, Stewart C, et al. Long-term vertigo control in patients after intratympanic gentamicin instillation for Meniere\u2019s disease. Otol Neurotol, 2007,28(8): 1140\u20131144","journal-title":"Otol Neurotol"},{"issue":"1","key":"1501_CR10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S0022215112002605","volume":"127","author":"J Wasson","year":"2013","unstructured":"Wasson, J, Upile N, Pfleiderer A. Intratympanic gentamicin treatment for unilateral Meniere\u2019s disease: long-term follow up of a proven regime. J Laryngol Otol, 2013,127(1):20\u201324","journal-title":"J Laryngol Otol"},{"issue":"3","key":"1501_CR11","first-page":"357","volume":"20","author":"JT Atlas","year":"1999","unstructured":"Atlas, JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Meniere\u2019s disease. Am J Otol, 1999, 20(3):357\u2013363","journal-title":"Am J Otol"},{"issue":"3","key":"1501_CR12","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.otohns.2010.05.028","volume":"143","author":"U Katzenell","year":"2010","unstructured":"Katzenell U, Gordon M, Page M. Intratympanic gentamicin injections for the treatment of Meniere\u2019s disease. Otolaryngol Head Neck Surg, 2010,143(5 Suppl 3):S24\u2013S29","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"1501_CR13","first-page":"33","volume":"13","author":"A Daneshi","year":"2014","unstructured":"Daneshi A, Jahandideh H, Pousti SB, et al. One-shot, low-dosage intratympanic gentamicin for Meniere\u2019s disease: Clinical, posturographic and vestibular test findings. Iran J Neurol, 2014,13(1):33\u201339","journal-title":"Iran J Neurol"},{"issue":"3","key":"1501_CR14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","volume":"113","author":"Committee on HearingEquilibrium guidelines for the diagnosisevaluation of therapy in Meni\u00e8re's disease.","year":"1995","unstructured":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meni\u00e8re's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc.. Otolaryngol Head Neck Surg, 1995, 113(3):181\u2013185","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"1501_CR15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3109\/00016489.2015.1052984","volume":"135","author":"B Liu","year":"2015","unstructured":"Liu B, Zhang S, Leng Y, et al. Intratympanic injection in delayed endolymphatic hydrops. Acta Otolaryngol, 2015,135(10):1016\u20131021","journal-title":"Acta Otolaryngol"},{"key":"1501_CR16","first-page":"61","volume-title":"Acta Otolaryngol Suppl","author":"WH Chung","year":"2007","unstructured":"Chung WH, Chung KW, Kim JH, et al. Effects of a single intratympanic gentamicin injection on Meniere\u2019s disease. Acta Otolaryngol Suppl, 2007(558):61\u201366"},{"issue":"6","key":"1501_CR17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00405-013-2597-7","volume":"271","author":"S Quaglieri","year":"2014","unstructured":"Quaglieri S, Gatti O, Rebecchi E, et al. Intratympanic gentamicin treatment \u2018as needed\u2019 for Meniere\u2019s disease. Long-term analysis using the Kaplan-Meier method. Eur Arch Otorhinolaryngol, 2014,271(6):1443\u20131449","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"1501_CR18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/00016480600951475","volume":"127","author":"L Beer De","year":"2007","unstructured":"De Beer L, Stokroos R, Kingma H. Intratympanic gentamicin therapy for intractable Meniere\u2019s disease. Acta Otolaryngol, 2007,127(6):605\u20136012","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"1501_CR19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0194599813520398","volume":"150","author":"AP Casani","year":"2014","unstructured":"Casani AP, Cerchiai N, Navari E, et al. Intratympanic gentamicin for Meniere\u2019s disease: short- and long-term follow-up of two regimens of treatment. Otolaryngol Head Neck Surg, 2014,150(5):847\u2013852","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"1501_CR20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/MAO.0b013e318259b3b1","volume":"33","author":"LK Huon","year":"2012","unstructured":"Huon LK, Fang TY, Wang PC. Outcomes of intratympanic gentamicin injection to treat Meniere\u2019s disease. Otol Neurotol, 2012,33(5):706\u2013714","journal-title":"Otol Neurotol"},{"issue":"5","key":"1501_CR21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00005537-200305000-00009","volume":"113","author":"IC Wu","year":"2003","unstructured":"Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Meniere\u2019s disease. Laryngoscope, 2003,113(5):815\u2013820","journal-title":"Laryngoscope"},{"issue":"2","key":"1501_CR22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00129492-200103000-00016","volume":"22","author":"SG Harner","year":"2001","unstructured":"Harner SG, Driscoll CL, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Meniere\u2019s syndrome. Otol Neurotol, 2001,22(2):210\u2013214","journal-title":"Otol Neurotol"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1501-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-015-1501-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1501-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:11:09Z","timestamp":1559409069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-015-1501-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1007\/s11596-015-1501-7","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}